These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3654953)

  • 1. Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Sep; 25(9):1796-9. PubMed ID: 3654953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites.
    Wise R; Andrews JM; Piddock LJ
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1067-72. PubMed ID: 3729361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
    Chau PY; Leung YK; Ng WW; Arnold K
    Antimicrob Agents Chemother; 1987 Mar; 31(3):473-6. PubMed ID: 3579264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
    Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1992; 15(8):693-701. PubMed ID: 1478050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
    Beskid G; Fallat V; Siebelist J; Durkin JW; Lipschitz ER; McGarry DH
    J Clin Microbiol; 1987 Jul; 25(7):1186-90. PubMed ID: 3112176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of RO 15-8074 and RO 19-5247.
    Valle T; Jalanko E; Scheinin L; Renkonen OV
    Eur J Clin Microbiol; 1987 Apr; 6(2):167-9. PubMed ID: 3109897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399.
    Pfaller MA; Barry AL; Fuchs PC
    Antimicrob Agents Chemother; 1993 Apr; 37(4):893-5. PubMed ID: 8494387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
    Neu HC; Chin NX; Labthavikul P
    Antimicrob Agents Chemother; 1986 Sep; 30(3):423-8. PubMed ID: 3490827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074.
    Aldridge KE; Schiro DD; Sanders CV
    Eur J Clin Microbiol; 1987 Oct; 6(5):564-9. PubMed ID: 3436316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility testing interpretive criteria and drug stability for cefdinir, cefetamet, and cefpodoxime against Neisseria gonorrhoeae.
    Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1992; 15(8):685-91. PubMed ID: 1478049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins.
    Fass RJ; Helsel VL
    Antimicrob Agents Chemother; 1986 Sep; 30(3):429-34. PubMed ID: 3777906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.
    Le Saux NM; Slaney LA; Plummer FA; Ronald AR; Brunham RC
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1153-4. PubMed ID: 2959199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807).
    Jones RN; Barry AL
    Antimicrob Agents Chemother; 1988 Apr; 32(4):443-9. PubMed ID: 3377457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretive criteria of antimicrobial disk susceptibility tests with cefpodoxime.
    Grimm H
    Infection; 1991; 19(5):380-2. PubMed ID: 1800381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ro 15-8075 (cefetamet pivoxyl), a new oral cephalosporin: in vitro activity of the free acid Ro 15-8074 and regression line analyses.
    Grimm K; Grimm H
    Chemioterapia; 1987 Jun; 6(2 Suppl):84-7. PubMed ID: 3509540
    [No Abstract]   [Full Text] [Related]  

  • 16. Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates.
    Jones RN; Erwin ME; Gooding BB
    J Clin Microbiol; 1992 Apr; 30(4):1022-3. PubMed ID: 1572959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary interpretive susceptibility testing criteria for FK-037 with 30-microgram disks.
    Jones RN
    J Clin Microbiol; 1994 Apr; 32(4):1104-6. PubMed ID: 8027323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef.
    Biedenbach DJ; Jones RN
    J Clin Microbiol; 1994 Feb; 32(2):559-62. PubMed ID: 8150976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antimicrobial activity of ceftibuten against multiply-resistant microorganisms from Belgium.
    Verbist L; Jacobs J; Hens K
    Diagn Microbiol Infect Dis; 1991; 14(1):53-61. PubMed ID: 1901535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
    Simon C
    Infection; 1987; 15(2):122-4. PubMed ID: 3596808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.